Vitamin D and cardiovascular disease: a jack of all trades?

by Rudolf A de Boer
Published 2011-06-01

Transforming heart failure and cardio‐oncology care during COVID‐19

by Valentina Bracun, Rudolf A. deBoer
Published 2020-12-01

Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease

by Joseph Pierre Aboumsallem, Javid Moslehi, Rudolf A. de Boer
Published 2020-01-01

Haemodynamic monitoring as an opportunity for tailoring diuretics and guideline‐directed medical therapy in heart failure

by Jishnu Malgie, Jasper J. Brugts, Rudolf A. deBoer
Published 2023-09-01

Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?

by Salva R. Yurista, Herman H. W. Silljé, Michiel Rienstra, Rudolf A. de Boer, B. Daan Westenbrink
Published 2020-01-01

Shift work is associated with 10-year incidence of atrial fibrillation in younger but not older individuals from the general population: results from the Tromsø Study

by Rudolf A de Boer, Michiel Rienstra, Tom Wilsgaard, Maja-Lisa Løchen, Victor W Zwartkruis, Ekaterina Sharashova
Published 2022-08-01

The role of immune checkpoints in cardiovascular disease

by Laura I. Yousif, Anniek A. Tanja, Rudolf A. de Boer, Arco J. Teske, Wouter C. Meijers
Published 2022-10-01

The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies

by Nienke M. Stege, Rudolf A. de Boer, Maarten P. van den Berg, Herman H. W. Silljé
Published 2021-03-01

Renal effects of long-term darbepoetin alpha treatment in hypertensive TGR(mRen2)27 rats

by Anne-Roos S Frenay, Willem-Peter T Ruifrok, Marian Bulthuis, Sippie Huitema, Rudolf A de Boer, Harry van Goor
Published 2012-06-01

Unraveling the Genotype‐Phenotype Relationship in Hypertrophic Cardiomyopathy: Obesity‐Related Cardiac Defects as a Major Disease Modifier

by Edgar E. Nollet, B. Daan Westenbrink, Rudolf A. de Boer, Diederik W. D. Kuster, Jolanda van der Velden
Published 2020-11-01

The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general population

by Arnold Piek, Leonie Smit, Navin Suthahar, Stephan J. L. Bakker, Rudolf A. de Boer, Herman H. W. Silljé
Published 2021-04-01

Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta‐Analysis

by Giacomo Tini, Edoardo Bertero, Alessio Signori, Maria Pia Sormani, Christoph Maack, Rudolf A. De Boer, Marco Canepa, Pietro Ameri
Published 2020-09-01

Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?

by Suzanne N. Voorrips, Huitzilihuitl Saucedo-Orozco, Pablo I. Sánchez-Aguilera, Rudolf A. De Boer, Peter Van der Meer, B. Daan Westenbrink
Published 2022-08-01

Dual RAAS suppression: recent developments and implications in light of the ALTITUDE study

by Rudolf A de Boer, Michel Azizi, AH Jan Danser, Geneviève Nguyen, Jürg Nussberger, Luis M Ruilope, Roland E Schmieder, Massimo Volpe
Published 2012-09-01

Lifestyle components: Self-reported physical activity, nutritional status, sleep quality and incident atrial fibrillation

by Joylene E. Siland, Victor Zwartkruis, Bastiaan Geelhoed, Rudolf A. de Boer, Isabelle C. van Gelder, Pim van der Harst, Michiel Rienstra
Published 2020-04-01

Established Tumour Biomarkers Predict Cardiovascular Events and Mortality in the General Population

by Valentina Bracun, Navin Suthahar, Canxia Shi, Sanne de Wit, Wouter C. Meijers, IJsbrand T. Klip, Rudolf A. de Boer, Joseph Pierre Aboumsallem
Published 2021-12-01

The Plk1 inhibitor BI 2536 temporarily arrests primary cardiac fibroblasts in mitosis and generates aneuploidy in vitro.

by Bo Lu, Hasan Mahmud, Alexander H Maass, Bo Yu, Wiek H van Gilst, Rudolf A de Boer, Herman H W Silljé
Published 2010-01-01

Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes

by Amy Groenewegen, Victor W. Zwartkruis, Betül Cekic, Rudolf. A. de Boer, Michiel Rienstra, Arno W. Hoes, Frans H. Rutten, Monika Hollander
Published 2021-06-01

Telomere length of circulating leukocyte subpopulations and buccal cells in patients with ischemic heart failure and their offspring.

by Liza S M Wong, Jardi Huzen, Rudolf A de Boer, Wiek H van Gilst, Dirk J van Veldhuisen, Pim van der Harst
Published 2011-01-01

The association of multimorbidity within cardio-metabolic disease domains with dietary patterns: A cross-sectional study in 129 369 men and women from the Lifelines cohort.

by Louise H Dekker, Martin H de Borst, Laura M G Meems, Rudolf A de Boer, Stephan J L Bakker, Gerjan J Navis
Published 2019-01-01